regenesys.eu valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | ReGenesys |
| Description | Home ReGenesys is a biopharmaceutical company focused on the research and development of stem cell based |
| Keywords | biopharmaceutical, ReGenesys, stem cell, Athersys, clinical study, MultiStem , bone marrow, AMI, GVHD |
Server Information
| WebSite | |
| Host IP | 185.162.30.33 |
| Location | - |
Related Websites
| Site | Rank |
More to Explore
regenesys.eu Valuation
|
US$952,083
Last updated: 2022-09-17 18:25:44
regenesys.eu has Semrush global rank of 11,117,002. regenesys.eu has an estimated worth of US$ 952,083, based on its estimated Ads revenue. regenesys.eu receives approximately 109,856 unique visitors each day. Its web server is located in -, with IP address 185.162.30.33. According to SiteAdvisor, regenesys.eu is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$952,083 |
| Daily Ads Revenue | US$879 |
| Monthly Ads Revenue | US$26,366 |
| Yearly Ads Revenue | US$316,385 |
| Daily Unique Visitors | 7,324 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| regenesys.eu. | A | 7199 | IP: 185.162.30.33 |
| regenesys.eu. | NS | 3600 | NS Record: ns4.combell.net. |
| regenesys.eu. | NS | 3600 | NS Record: ns3.combell.net. |
| regenesys.eu. | MX | 10800 | MX Record: 10 us-smtp-inbound-2.mimecast.com. |
| regenesys.eu. | MX | 10800 | MX Record: 10 us-smtp-inbound-1.mimecast.com. |
| regenesys.eu. | TXT | 10800 | TXT Record: v=spf1 a:dispatch-us.ppe-hosted.com include:_netblocks.mimecast.com ~all |
| regenesys.eu. | TXT | 3600 | TXT Record: MS=ms57439245 |
| regenesys.eu. | TXT | 3600 | TXT Record: docusign=c7733a09-0aa1-48a1-b391-2d1f9d9c37da |
HtmlToTextCheckTime:2022-09-17 18:25:44
| Info request l print page Home About Leadership Links Projects Home About Leadership Links Contact --> News --> Contact Home ReGenesys is a wholly owned subsidiary of Athersys Inc. (NASDAQ: ATHX), a publicly held biotechnology company in Cleveland, Ohio. Athersys is developing MultiStem® cell therapy, a patented, adult-derived, “off-the-shelf” stem cell product. ReGenesys is focused on the R&D that supports the MultiStem® clinical programs and is developing potential new regenerative medicine opportunities, such as animal health care. Nieuws © 2012 REGENESYS BVBA - Bio-Incubator Leuven - Gaston Geenslaan 1 - 3001 Heverlee . Belgium - T: +32 16 751 355 - F: +32 16 751 351 - info@regenesys.eu Design by |
HTTP Headers
HTTP/1.1 200 OK Server: nginx Date: Sat, 25 Dec 2021 09:04:32 GMT Content-Type: text/html; charset=UTF-8 Connection: keep-alive Expires: Mon, 26 Jul 1997 05:00:00 GMT Pragma: no-cache Set-Cookie: exp_last_visit=1325063072; expires=Sun, 25-Dec-2022 09:04:32 GMT; Max-Age=31536000; path=/ Set-Cookie: exp_last_activity=1640423072; expires=Sun, 25-Dec-2022 09:04:32 GMT; Max-Age=31536000; path=/ Set-Cookie: exp_tracker=a%3A1%3A%7Bi%3A0%3Bs%3A5%3A%22index%22%3B%7D; path=/ Last-Modified: Sat, 25 Dec 2021 09:04:32 GMT |
regenesys.eu Whois Information
Domain: regenesys.eu Script: LATIN NOT DISCLOSED! Visit www.eurid.eu for webbased WHOIS. Organisation: COMBELL GROUP NV Language: nl Email: jonas.dhaenens@domaincentral.info Name: Combell NV Website: http://www.combell.com ns3.combell.net ns4.combell.net Please visit www.eurid.eu for more info. |